This asymmetry in glioma CSCs is ensured by different distribution of the GFR (EGFR) molecules, transcription factors (e.g., Oct4, Sox2, etc.), membrane glycoproteins and proteoglycans (CD133, NG2) regulating stem cell properties and suppressing differentiation. The gene discussed is POU5F1; the disease is central nervous system cancer.